EUVIMEDEUVIMED entdecken
Crossref

Nrf2 prevents diabetic cardiomyopathy via antioxidant effect and normalization of glucose and lipid metabolism in the heart

Ge Yang, Qihe Zhang, Chao Dong, Guowen Hou, Jinjie Li, Xin Jiang, Ying Xin iD

Journal of Cellular Physiology · 2024-02 · 239 (2)

DOI: 10.1002/jcp.31149 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Cellular Physiology, online erschienen am 03.02.2024. Verfasst von Ge Yang und 6 weiteren Autor:innen. Beteiligte Einrichtung: Key Laboratory of Pathobiology, Ministry of Education, College of Basic Medical Sciences, Jilin University, Changchun, Jilin, China. Hauptthemen laut MEDLINE: Diabetic Cardiomyopathies, Diabetes Mellitus, Experimental. Die Arbeit wurde bisher 24-mal zitiert (Crossref) und nennt 84 Literaturangaben. Gefördert von: National Natural Science Foundation of China, Jilin Provincial Science and Technology Foundations, Chang chun science and technology bureau development plan project.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Metabolic disorders and oxidative stress are the main causes of diabetic cardiomyopathy. Activation of nuclear factor erythroid 2‐related factor 2 (Nrf2) exerts a powerful antioxidant effect and prevents the progression of diabetic cardiomyopathy. However, the mechanism of its cardiac protection and direct action on cardiomyocytes are not well understood. Here, we investigated in a cardiomyocyte‐restricted Nrf2 transgenic mice (Nrf2‐TG) the direct effect of Nrf2 on cardiomyocytes in DCM and its mechanism. In this study, cardiomyocyte‐restricted Nrf2 transgenic mice (Nrf2‐TG) were used to directly observe whether cardiomyocyte‐specific overexpression of Nrf2 can prevent diabetic cardiomyopathy and correct glucose and lipid metabolism disorders in the heart. Compared to wild‐type mice, Nrf2‐TG mice showed resistance to diabetic cardiomyopathy in a streptozotocin‐induced type 1 diabetes mouse model. This was primarily manifested as improved echocardiography results as well as reduced myocardial fibrosis, cardiac inflammation, and oxidative stress. These results showed that Nrf2 can directly act on cardiomyocytes to exert a cardioprotective role. Mechanistically, the cardioprotective effects of Nrf2 depend on its antioxidation activity, partially through improving glucose and lipid metabolism by directly targeting lipid metabolic pathway of AMPK/Sirt1/PGC‐1α activation via upstream genes of sestrin2 and LKB1, and indirectly enabling AKT/GSK‐3β/HK‐Ⅱ activity via AMPK mediated p70S6K inhibition.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Diabetic CardiomyopathiesDiabetes Mellitus, ExperimentalMiceAnimalsAntioxidantsNF-E2-Related Factor 2GlucoseAMP-Activated Protein KinasesLipid MetabolismGlycogen Synthase Kinase 3 betaSignal TransductionMyocytes, CardiacOxidative StressMice, Transgenic

Stichwörter der Autor:innen

Nrf2diabetic cardiomyopathyglucose metabolic disorderlipid metabolic disorderoxidative stress

Substanzen

AntioxidantsNF-E2-Related Factor 2GlucoseAMP-Activated Protein KinasesGlycogen Synthase Kinase 3 beta

Autor:innen und Institutionen

  • Key Laboratory of Pathobiology, Ministry of Education, College of Basic Medical Sciences, Jilin University, Changchun, Jilin, China.
  • Jilin Provincial Key Laboratory of Radiation Oncology & Therapy, The First Hospital of Jilin University, and Key Laboratory of Pathobiology, Ministry of Education, Jilin University, Changchun, Jilin, China.
  • Department of Radiation Oncology, The First Hospital of Jilin University, Changchun, Jilin, China.
  • NHC Key Laboratory of Radiobiology, School of Public Health, Jilin University, Changchun, Jilin, China.

ORCID-Profile: Ying Xin

Förderung

  • National Natural Science Foundation of China
  • Jilin Provincial Science and Technology Foundations
  • Chang chun science and technology bureau development plan project

Zitieren

APA

Yang, G., Zhang, Q., Dong, C., Hou, G., Li, J., Jiang, X., & Xin, Y. (2024). Nrf2 prevents diabetic cardiomyopathy via antioxidant effect and normalization of glucose and lipid metabolism in the heart. Journal of Cellular Physiology, 239(2). https://doi.org/10.1002/jcp.31149

Vancouver

Yang G, Zhang Q, Dong C, Hou G, Li J, Jiang X, et al. Nrf2 prevents diabetic cardiomyopathy via antioxidant effect and normalization of glucose and lipid metabolism in the heart. Journal of Cellular Physiology. 2024;239(2). doi:10.1002/jcp.31149

BibTeX
@article{Yang2024,
  author = {Yang, Ge and Zhang, Qihe and Dong, Chao and Hou, Guowen and Li, Jinjie and Jiang, Xin and Xin, Ying},
  title = {Nrf2 prevents diabetic cardiomyopathy via antioxidant effect and normalization of glucose and lipid metabolism in the heart},
  journal = {Journal of Cellular Physiology},
  year = {2024},
  volume = {239},
  number = {2},
  doi = {10.1002/jcp.31149}
}
Kostenlos starten →